Medicine
BEVACIZUMAB 100 CIPLA
Key ingredient(s)
Bevacizumab
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| CONCENTRATE FOR SOLUTION FOR INFUSION | 100,0 mg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bpKcVZQaXycO5S5Cp98C-fpJRX7h-PwCVnFlNLzI7MT5KJkS33TAVUpb_J0aOUZt3LsqIBBSiUWsrB69-rhnD_zUImPMGo_kuFJFBQ3LiKuVA | Reg: 57/30.1/0232 | AppNo: 570232 | RegDate: 2024/11/19 | Applicant: Cipla Medpro (Pty) Ltd | Status: Registered